XML 19 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statement of Cash Flows Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows - operation activities:    
Net (loss)/earnings $ (3,502) $ 374
Non-cash items -    
Share-based plans expense 165 160
Depreciation and amortization 1,668 1,643
Investment/asset impairment charges, net 317 106
Customer financing valuation adjustments 12 249
Gain on dispositions, net (200) (296)
Other charges and credits, net 912 190
Changes in assets and liabilities -    
Accounts receivable 125 315
Unbilled receivables 56 (1,053)
Advances and progress billings 428 2,355
Inventories 9,653 9,565
Other current assets 319 (224)
Accounts payable (3,303) 1,626
Accrued liabilities 967 5,495
Income taxes receivable, payable and deferred (2,404) (989)
Other long-term liabilities (149) (577)
Pension and other postretirement plans (556) (570)
Customer financing, net 108 391
Other 289 144
Net cash used by operating activities (14,401) (226)
Cash flows - investing activities:    
Property, plant and equipment additions (1,038) (1,387)
Property, plant and equipment reductions 275 334
Acquisitions, net of cash acquired   (492)
Contributions to investments (25,846) (1,439)
Proceeds from investments 9,772 967
Purchase of distribution rights   20
Other 14 (10)
Net cash used by investing activities (16,823) (2,047)
Cash flows - financing activities:    
New borrowings 42,362 19,621
Debt repayments (8,792) (8,978)
Contributions from noncontrolling interests   7
Stock options exercised 31 51
Employee taxes on certain share-based payment arrangements (169) (241)
Common shares repurchased   (2,651)
Dividends paid (1,158) (3,473)
Net cash provided by financing activities 32,274 4,336
Effect of exchange rate changes on cash and cash equivalents, including restricted 26 (27)
Net increase in cash & cash equivalents, including restricted 1,076 2,036
Cash & cash equivalents, including restricted, at beginning of year 9,571 7,813
Cash & cash equivalents, including restricted, at end of period 10,647 9,849
Restricted Cash and Cash Equivalents (83) [1] (86)
Cash and cash equivalents at end of period $ 10,564 $ 9,763
[1] Reflects amounts restricted in support of our workers’ compensation programs, employee benefit programs, and insurance premiums.